Program
TolaSure Topical Gel
Also written as “5% TolaSure Topical Gel”.
Its studies are mostly in Epidermolysis Bullosa Simplex, led by BioMendics.
Furthest: phase 2, since Sep 11, 20194 company-led studies, 1 open or runningNext primary completion: Jan 2027 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| BioMendics | 41 open or running | phase 2since Sep 11, 2019 | Jul 10, 2018 | Jan 2027phase 2 · NCT07027345 |
Also a collaborator on its studies: Symbio.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 10, 2018First study: phase 1 study in Wound HealingFirst studyNCT03620175 · 22 enrolled · United States
- Sep 11, 2019Phase 2 study in Wound HealingNCT04088357 · 72 enrolled · United States
- Sep 21, 2021Phase 1 study in Epidermolysis Bullosa SimplexNCT05062070 · 6 enrolled · United States
- Jun 9, 2025Phase 2 study in Epidermolysis Bullosa SimplexNCT07027345 · 40 planned · United States
Ahead
- Jan 2027Primary completion: phase 2 study in Epidermolysis Bullosa SimplexNCT07027345
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07027345Epidermolysis Bullosa Simplex · United States | 2 | Recruiting | Jan 2027 | 40 |
| NCT05062070Epidermolysis Bullosa Simplex · United States | 1 | Completed | Jun 22, 2023 | 6 |
| NCT04088357Wound Healing · United States | 2 | Completed | Apr 22, 2020 | 72 |
| NCT03620175Wound Healing · United States | 1 | Completed | Dec 12, 2018 | 22 |
How it is read
Names in the registry
- “TolaSure Topical Gel”, 3 entries
- “5% TolaSure Topical Gel”, 1 entry
Conditions, from the studies’ own filings
- Epidermolysis Bullosa Simplex, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.